Home Tools
Log in
Cart

mTOR

The mammalian target of rapamycin (mTOR), sometimes also referred to as the mechanistic target of rapamycin and FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1), is a kinase that in humans is encoded by the MTOR gene. mTOR is a member of the phosphatidylinositol 3-kinase-related kinase family of protein kinases.mTOR links with other proteins and serves as a core component of two distinct protein complexes, mTOR complex 1 and mTOR complex 2, which regulate different cellular processes. In particular, as a core component of both complexes, mTOR functions as a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, autophagy, and transcription. As a core component of mTORC2, mTOR also functions as a tyrosine protein kinase that promotes the activation of insulin receptors and insulin-like growth factor 1 receptors. mTORC2 has also been implicated in the control and maintenance of the actin cytoskeleton.
Signaling Pathways | Target | TargetMol
Cat. No. Product name CAS No. Purity Chemical Structure
T1958 AZ20 1233339-22-4 98.02%
AZ20
AZ20 is an effective and specific inhibitor of ATR kinase (IC50: 5 nM, in a cell-free assay), 8-fold selectivity over mTOR.
T2357 GSK1059615 958852-01-2 98%
GSK1059615
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
T3705 GDC0084 1382979-44-3 98%
GDC0084
GDC0084 (RG7666) is a PI3K inhibitor with potential antineoplastic activity. GDC0084 (RG7666) specifically inhibits PI3K in the PI3K/AKT kinase (or protein kinas...
T2083 PI-3065 955977-50-1 98%
PI-3065
PI-3065 is a novel potent and selective PI3K p110δ inhibitor.
T7166 GNE-493 1033735-94-2 98%
GNE-493
GNE-493 is potent, selective, and orally available PI3K and mTOR inhibitor with potential anticancer activity.IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for ...
T6820 D-α-Hydroxyglutaric acid disodium 103404-90-6 98%
D-α-Hydroxyglutaric acid disodium
D-α-Hydroxyglutaric acid disodium (Disodium (R)-2-Hydroxyglutarate) is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases with Ki of 0.628 mM.
T1859 AZD-8055 1009298-09-2 98%
AZD-8055
AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms.
T6319 OSI-027 936890-98-1 98%
OSI-027
OSI-027 (ASP4786) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTO...
T6334 Ridaforolimus 572924-54-0 98%
Ridaforolimus
Ridaforolimus (AP23573) is a small molecule and non-prodrug analogue of the lipophilic macrolide antibiotic rapamycin with potential antitumor activity. Ridaforo...
T1961 Vistusertib 1009298-59-2 97.94%
Vistusertib
Vistusertib (AZD2014) is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity.
T9314 CC214-1 1021920-32-0 97.87%
CC214-1
CC214-1 is an mTOR inhibitor with potential anticancer activity, inhibits protein translation, and induces autophagy. CC214-1 is an in vitro tool compound for ex...
T2974 Cyclovirobuxine D 860-79-7 97.78%
Cyclovirobuxine D
Cyclovirobuxine D (Bebuxine) is extracted from Buxus microphylla.
T1908 MHY1485 326914-06-1 97.74%
MHY1485
MHY1485 is a mTOR activator. It inhibits the autophagic process by inhibition of fusion between autophagosomes and lysosomes, leading to the accumulation of LC3I...
T6354 (+)-Usnic acid 7562-61-0 97.61%
(+)-Usnic acid
(+)-Usnic acid (D-Usnic Acid) is a naturally occurring dibenzofuran derivative found in several lichen species.
T4423 LY 303511 hydrochloride 2070014-90-1 97.44%
LY 303511 hydrochloride
LY 303511 hydrochloride is a potent mTOR inhibitor
TN1405 Arnicolide D 34532-68-8 96.66%
Arnicolide D
Arnicolide D is a sesquiterpene lactone. Arnicolide D isolates from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling path...
T14033 3BDO 890405-51-3 96.00%
3BDO
3BDO is an activator of mTOR. It can also inhibit autophagy..
T6072L BGT226 915020-55-2 95.74%
BGT226
BGT226 (NVP-BGT226) is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.
T3541 CC-115 1228013-15-7 86.79%
CC-115
CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM).
T4199 Desmethyl-VS-5584 1246535-95-4 100%
Desmethyl-VS-5584
Desmethyl-VS-5584 is a dimethyl analog of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
AZ20
T1958
AZ20 is an effective and specific inhibitor of ATR kinase (IC50: 5 nM, in a cell-free assay), 8-fold selectivity over mTOR.
GSK1059615
T2357
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
GDC0084
T3705
GDC0084 (RG7666) is a PI3K inhibitor with potential antineoplastic activity. GDC0084 (RG7666) specifically inhibits PI3K in the PI3K/AKT kinase (or protein kinas...
PI-3065
T2083
PI-3065 is a novel potent and selective PI3K p110δ inhibitor.
GNE-493
T7166
GNE-493 is potent, selective, and orally available PI3K and mTOR inhibitor with potential anticancer activity.IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for ...
D-α-Hydroxyglutaric acid disodium
T6820
D-α-Hydroxyglutaric acid disodium (Disodium (R)-2-Hydroxyglutarate) is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases with Ki of 0.628 mM.
AZD-8055
T1859
AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms.
OSI-027
T6319
OSI-027 (ASP4786) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTO...
Ridaforolimus
T6334
Ridaforolimus (AP23573) is a small molecule and non-prodrug analogue of the lipophilic macrolide antibiotic rapamycin with potential antitumor activity. Ridaforo...
Vistusertib
T1961
Vistusertib (AZD2014) is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity.
CC214-1
T9314
CC214-1 is an mTOR inhibitor with potential anticancer activity, inhibits protein translation, and induces autophagy. CC214-1 is an in vitro tool compound for ex...
Cyclovirobuxine D
T2974
Cyclovirobuxine D (Bebuxine) is extracted from Buxus microphylla.
MHY1485
T1908
MHY1485 is a mTOR activator. It inhibits the autophagic process by inhibition of fusion between autophagosomes and lysosomes, leading to the accumulation of LC3I...
(+)-Usnic acid
T6354
(+)-Usnic acid (D-Usnic Acid) is a naturally occurring dibenzofuran derivative found in several lichen species.
LY 303511 hydrochloride
T4423
LY 303511 hydrochloride is a potent mTOR inhibitor
Arnicolide D
TN1405
Arnicolide D is a sesquiterpene lactone. Arnicolide D isolates from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling path...
3BDO
T14033
3BDO is an activator of mTOR. It can also inhibit autophagy..
BGT226
T6072L
BGT226 (NVP-BGT226) is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.
CC-115
T3541
CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM).
Desmethyl-VS-5584
T4199
Desmethyl-VS-5584 is a dimethyl analog of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
1 2 3 4 5 6 7 8
TargetMol